GL検索 v0.1.0
この版は旧版です。新版があります: JSPM 2020 がん疼痛の薬物療法に関するガイドライン(2020年版) 新版を読む
画像は 213 ページを描画したものです
page 213

p.213 抽出テキスト

III章推奨

14)Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2008; 2 15)Mercadante S, Arcuri E, Tirelli W. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled,double-blind crossover study. Tumori 2002; 88: 239-42 16)Challapalli V, Tremont-Lukats IW, McNicol et al. Systemic administration of local anesthetic agents to relieve pain. Cochrane Database Syst Rev 2005; 4 17)Ellemann K, Sjogren P, Banning AM, et al. Trial of intravenous lidocaine on painful neuropathy in cancer patients. Clin J Pain 1989; 5: 291-4 18)Bruera E, Ripamonti C, Brenneis C, et al. A randomized double-blind crossover trial of intravenous lidocaine in the treatmentof neuropathic cancer pain. J Pain Symptom Manage 1992; 7: 138-40 19)Sharma S, Rajagopal MR, Palat G, et al. A phase II pilot study to evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients. J Pain Symptom Manage 2009 ; 37 : 85-93 20)von Gunten CF, Eappen S, Cleary JF, et al. Flecainide for the treatment of chronic neuropathic pain: a Phase II trial. Palliat Med 2007; 21: 667-72

臨床疑問45 21)Gilron I, Bailey JM, Tu D, et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009; 374(9697): 1252-61